- Global Pharma News & Resources

Global Tyrosine Kinase Inhibitors Market by Product, Application, Distribution Channel and Geography - Forecast to 2027 -

The "Global Tyrosine Kinase Inhibitors Market Analysis & Trends - Industry Forecast to 2027" report has been added to's offering.

The Global Tyrosine Kinase Inhibitors Market is poised to grow strong during the forecast period 2017 to 2027.

Some of the prominent trends that the market is witnessing include rising awareness about cancer diagnosis, increasing disease incidences and technological developments among high-quality products.


  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, regions and countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Topics Covered

1 Market Outline

2 Executive Summary

3 Market Overview

4 Tyrosine Kinase Inhibitors Market, By Product

4.1 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors

4.2 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors

4.3 BCR-ABL Tyrosine Kinase Inhibitors

4.4 Other Products

5 Tyrosine Kinase Inhibitors Market, By Application

5.1 Renal Cell Cancer

5.2 Lung Cancer

5.3 Chronic Myeloid Leukemia (CML)

5.4 Breast Cancer

5.5 Other Applications

6 Tyrosine Kinase Inhibitors Market, By Distribution Channel

6.1 Independent Pharmacies

6.2 Online Pharmacies

6.3 Hospital Pharmacies

7 Tyrosine Kinase Inhibitors Market, By Geography

8 Key Player Activities

9 Leading Companies

9.1 Tolero Pharmaceutical

9.2 Sanofi


9.4 Pfizer

9.5 Onyx Pharmaceuticals

9.6 Novartis

9.7 Merck

9.8 Johnson & Johnson

9.9 Incyte Corporation

9.10 GalaxoSmithKline

9.11 Exelixis

9.12 Chugai Pharmaceutical

9.13 Celgene Corporation

9.14 Bristol-Myer Squibb

9.15 Boehringer Ingelheim

9.16 Biogen Idec

9.17 Bayer Healthcare Pharmaceuticals

9.18 AstraZeneca

9.19 Array Pharmaceuticals

9.20 Advenchen Laboratories

For more information about this report visit

View source version on

Editor Details

Last Updated: 31-Jan-2019